SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-035576
Filing Date
2022-02-11
Accepted
2022-02-11 06:28:53
Documents
2
Group Members
ARTAL GROUP S.A.ARTAL INTERNATIONAL MANAGEMENT S.A.INVUS PUBLIC EQUITIES ADVISORS, LLCINVUS PUBLIC EQUITIES, L.P.MR. AMAURY WITTOUCKSTICHTING ADMINISTRATIEKANTOOR WESTENDWESTEND S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13G d299673dsc13g.htm SC 13G 138163
2 EX-99.1 d299673dex991.htm EX-99.1 11003
  Complete submission text file 0001193125-22-035576.txt   151190
Mailing Address VALLEY PARK 44, RUE DE LA VALLEE LUXEMBOURG N4 L-2661
Business Address VALLEY PARK 44, RUE DE LA VALLEE LUXEMBOURG N4 L-2661 352224259-1
Artal International S.C.A. (Filed by) CIK: 0001218180 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Subject) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89552 | Film No.: 22616578
SIC: 2834 Pharmaceutical Preparations